This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
Genomic Biomarker Testing
PEACE-3 Trial
PROfound Trial
PSMAfore Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
CAPItello-281 Trial
PSMAddition Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
BOND-003 Cohort P
CORE-001 Study
CORE-008
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Daniel D. Joyce, MD, MS
Bladder Cancer
Non-Muscle Invasive Bladder Cancer
Ashish Kamat, MD
Muscle-Invasive Bladder Cancer
Advanced & Metastatic Bladder Cancer (mUC)
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Biochemical Recurrence in Prostate Cancer
Decipher® Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
Testicular, Penile & Rare GU Malignances
Testicular Cancer
Science in GU Oncology
Bishoy M. Faltas, MD
Functional Urology
Functional Urology
Alan J. Wein, MD, PhD (hon.)
Urologic Catheters - CAUTI Challenges
Videos
Exclusives
Conferences
Disparities: Social Determinants of Health
Exclusive Collaborations
Health Policy in Urological Diseases
Independent Medical Education
Journal Clubs
Practice Guidelines Reviews
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Functional Urology
Men's Health
Pelvic Health
Actionable Clinical Data
Bladder Cancer
NMIBC with CIS: Evidence, Practice & Emerging Research
Risk-Stratified NMIBC Management
Trials in Progress
Prostate Cancer
Localized Prostate Cancer
CLARIFY
ESCAPE
FORT
NRG-GU 0101
RTIRE
High Risk BCR HSPC
ARASTEP
Oligometastatic Prostate Cancer
METANOVA
mHSPC
ARASEC
ASPIRE
MEVPRO-3
mCRPC
ECLIPSE
LEGION-100
MEVPRO-1 & 2
PROMISE
SECuRE
Bladder Cancer
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SNMMI 2026
ASCO 2026
AUA 2026
APCCC 2026
PSMA and Beyond 2026
All Conferences
View All
PCF
UroToday Home
Conference Highlights
AUA 2023
AUA 2023
Prostate Cancer
Testicular and Penile Cancer
Bladder Cancer
Stone Disease
Press Release
Kidney Cancer
Upper Tract Urothelial Carcinoma
AUA 2023 Kidney Cancer
Viewing 1-20 of 22 articles
AUA 2023: Development of an Individual Postoperative Prediction Model for Kidney Cancer Recurrence Using Machine Learning (UroCCR Study 120)
AUA 2023: The Metastatic Potential of Renal Masses is Underappreciated: A Size Analysis Stratified By Histology
AUA 2023: Cost-Effectiveness Analysis of Universal CT Staging Versus Selective CT Staging Strategies for Patients with cT1a Renal Masses
AUA 2023: True Local Recurrence Following Partial Nephrectomy
AUA 2023: Is a Renal Tumour Benign or Malignant? A Prediction Tool Including Patients Managed with Surgery, Ablation, or Surveillance
AUA 2023: Evaluation of American Urological Association Renal Cell Carcinoma Risk Groups for Chromophobe Renal Cell Carcinoma
AUA 2023: Assessing Utilization of Renal Mass Biopsy in the Management of T1a vs. T1b Renal Masses
AUA 2023: Role of Adjuvant Immunotherapy for Patients with Renal Cell Carcinoma at Increased Risk of Recurrence Following Resection
AUA 2023: Development of Virtual Reality (VR) Simulation of Robot-Assisted Partial Nephrectomy using Metaverse
AUA 2023: First Analysis of the Safety and Efficacy of UGN-101 in the Treatment of Ureteral Tumors
AUA 2023: The Role of Cytoreductive Partial Nephrectomy
AUA 2023: Assessment of Surgical Complications in Patients with Metastatic Clear Cell RCC Receiving Perioperative Cabozantinib and Nivolumab on Cyto-KIK Clinical Trial
AUA 2023: Management of Metastatic Non-Clear Cell RCC
AUA 2023: Surgical Complications after Robotic Partial Nephrectomy
AUA 2023: Histologic Subtypes in Renal Cell Carcinoma and Implications for Treatment: Comparing and Contrasting Different Treatment Pathways/Options
AUA 2023: Panel Discussion: Small Renal Mass Management
AUA 2023: Crossfire: Controversies in Urology: Thermal Ablation Versus Partial Nephrectomy for a 3 Cm Renal Mass in a 49 Year Old Male
AUA 2023: Partial versus Radical Nephrectomy for Complex Renal Mass: Multicenter Comparative Analysis of Functional Outcomes (ROSULA Collaborative Group)
AUA 2023: Virtual Renal Mass Biopsy: Predicting Renal Tumor Histology on Abdominal CT Images using Machine Learning
AUA 2023: Generalizability of the MK-6482-004 Trial to Real-World VHL Patients: Results From a Prospective Surveillance Study
1
2
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free